Cargando…

The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility

Amorphous solid dispersions (ASDs) are a promising formulation approach for poorly soluble active pharmaceutical ingredients (APIs), because they ideally enhance both dissolution rate and solubility. However, the mechanism behind this is not understood in detail. In the present study, we investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Frank, Kerstin J, Westedt, Ulrich, Rosenblatt, Karin M, Hölig, Peter, Rosenberg, Jörg, Mägerlein, Markus, Fricker, Gert, Brandl, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500034/
https://www.ncbi.nlm.nih.gov/pubmed/23166440
http://dx.doi.org/10.2147/IJN.S36571
_version_ 1782250050075754496
author Frank, Kerstin J
Westedt, Ulrich
Rosenblatt, Karin M
Hölig, Peter
Rosenberg, Jörg
Mägerlein, Markus
Fricker, Gert
Brandl, Martin
author_facet Frank, Kerstin J
Westedt, Ulrich
Rosenblatt, Karin M
Hölig, Peter
Rosenberg, Jörg
Mägerlein, Markus
Fricker, Gert
Brandl, Martin
author_sort Frank, Kerstin J
collection PubMed
description Amorphous solid dispersions (ASDs) are a promising formulation approach for poorly soluble active pharmaceutical ingredients (APIs), because they ideally enhance both dissolution rate and solubility. However, the mechanism behind this is not understood in detail. In the present study, we investigated the supramolecular and the nano/microparticulate structures that emerge spontaneously upon dispersion of an ASD in aqueous medium and elucidated their influence on solubility. The ASD, prepared by hot melt extrusion, contained the poorly soluble ABT-102 (solubility in buffer, 0.05 μg/mL), a hydrophilic polymer, and three surfactants. The apparent solubility of ABT-102 from the ASD-formulation was enhanced up to 200 times in comparison to crystalline ABT-102. At the same time, the molecular solubility, as assessed by inverse equilibrium dialysis, was enhanced two times. Asymmetrical flow field-flow fractionation in combination with a multiangle light-scattering detector, an ultraviolet detector, and a refractometer enabled us to separate and identify the various supramolecular assemblies that were present in the aqueous dispersions of the API-free ASD (placebo) and of binary/ternary blends of the ingredients. Thus, the supramolecular assemblies with a molar mass between 20,000 and 90,000 could be assigned to the polyvinylpyrrolidone/vinyl acetate 64, while two other kinds of assemblies were assigned to different surfactant assemblies (micelles). The amount of ABT-102 remaining associated with each of the assemblies upon fractionation was quantified offline with high-performance liquid chromatography–ultraviolet-visible. The polymeric and the micellar fraction contributed to the substantial increase in apparent solubility of ABT-102. Furthermore, a microparticulate fraction was isolated by centrifugation and analyzed by scanning electron microscopy, X-ray scattering, and infrared spectroscopy. The microparticles were found to be amorphous and to contain two of the surfactants besides ABT-102 as the main component. The amorphous microparticles are assumed to be the origin of the observed increase in molecular solubility (“true” supersaturation).
format Online
Article
Text
id pubmed-3500034
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-35000342012-11-19 The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility Frank, Kerstin J Westedt, Ulrich Rosenblatt, Karin M Hölig, Peter Rosenberg, Jörg Mägerlein, Markus Fricker, Gert Brandl, Martin Int J Nanomedicine Original Research Amorphous solid dispersions (ASDs) are a promising formulation approach for poorly soluble active pharmaceutical ingredients (APIs), because they ideally enhance both dissolution rate and solubility. However, the mechanism behind this is not understood in detail. In the present study, we investigated the supramolecular and the nano/microparticulate structures that emerge spontaneously upon dispersion of an ASD in aqueous medium and elucidated their influence on solubility. The ASD, prepared by hot melt extrusion, contained the poorly soluble ABT-102 (solubility in buffer, 0.05 μg/mL), a hydrophilic polymer, and three surfactants. The apparent solubility of ABT-102 from the ASD-formulation was enhanced up to 200 times in comparison to crystalline ABT-102. At the same time, the molecular solubility, as assessed by inverse equilibrium dialysis, was enhanced two times. Asymmetrical flow field-flow fractionation in combination with a multiangle light-scattering detector, an ultraviolet detector, and a refractometer enabled us to separate and identify the various supramolecular assemblies that were present in the aqueous dispersions of the API-free ASD (placebo) and of binary/ternary blends of the ingredients. Thus, the supramolecular assemblies with a molar mass between 20,000 and 90,000 could be assigned to the polyvinylpyrrolidone/vinyl acetate 64, while two other kinds of assemblies were assigned to different surfactant assemblies (micelles). The amount of ABT-102 remaining associated with each of the assemblies upon fractionation was quantified offline with high-performance liquid chromatography–ultraviolet-visible. The polymeric and the micellar fraction contributed to the substantial increase in apparent solubility of ABT-102. Furthermore, a microparticulate fraction was isolated by centrifugation and analyzed by scanning electron microscopy, X-ray scattering, and infrared spectroscopy. The microparticles were found to be amorphous and to contain two of the surfactants besides ABT-102 as the main component. The amorphous microparticles are assumed to be the origin of the observed increase in molecular solubility (“true” supersaturation). Dove Medical Press 2012 2012-11-12 /pmc/articles/PMC3500034/ /pubmed/23166440 http://dx.doi.org/10.2147/IJN.S36571 Text en © 2012 Frank et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Frank, Kerstin J
Westedt, Ulrich
Rosenblatt, Karin M
Hölig, Peter
Rosenberg, Jörg
Mägerlein, Markus
Fricker, Gert
Brandl, Martin
The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility
title The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility
title_full The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility
title_fullStr The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility
title_full_unstemmed The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility
title_short The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility
title_sort amorphous solid dispersion of the poorly soluble abt-102 forms nano/microparticulate structures in aqueous medium: impact on solubility
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500034/
https://www.ncbi.nlm.nih.gov/pubmed/23166440
http://dx.doi.org/10.2147/IJN.S36571
work_keys_str_mv AT frankkerstinj theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT westedtulrich theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT rosenblattkarinm theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT holigpeter theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT rosenbergjorg theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT magerleinmarkus theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT frickergert theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT brandlmartin theamorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT frankkerstinj amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT westedtulrich amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT rosenblattkarinm amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT holigpeter amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT rosenbergjorg amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT magerleinmarkus amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT frickergert amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility
AT brandlmartin amorphoussoliddispersionofthepoorlysolubleabt102formsnanomicroparticulatestructuresinaqueousmediumimpactonsolubility